{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:14:37Z","timestamp":1785870877512,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507800"],"award-info":[{"award-number":["2023YFC2507800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170128"],"award-info":[{"award-number":["82170128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070137"],"award-info":[{"award-number":["82070137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270129"],"award-info":[{"award-number":["82270129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270128"],"award-info":[{"award-number":["82270128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.09.027","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:01:59Z","timestamp":1758067319000},"page":"6366-6378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correction of VWF multimerization in type 2A\/IIC von Willebrand disease by exogenous VWF propeptide supplementation"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0873-9584","authenticated-orcid":false,"given":"Ziqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenman","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-5760","authenticated-orcid":false,"given":"Jing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.09.027_bib1","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's Disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.09.027_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.09.027_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2516.2007.01610.x","article-title":"The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007)","volume":"14","author":"Federici","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.ymthe.2025.09.027_bib4","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/pbc.24335","article-title":"The use of DDAVP in children with bleeding disorders","volume":"60","author":"Ben-Ami","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ymthe.2025.09.027_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective, multicenter study","volume":"99","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib6","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1182\/blood-2005-09-3605","article-title":"Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor","volume":"107","author":"De Meyer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/hum.2011.238","article-title":"In vivo gene transfer strategies to achieve partial correction of von Willebrand disease","volume":"23","author":"Wang","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.027_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41434-020-00218-6","article-title":"Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor","volume":"30","author":"Barbon","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.027_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood-2013-11-540534","article-title":"A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in mice","volume":"124","author":"Yee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jth.15131","article-title":"In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A","volume":"19","author":"Campioni","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib11","article-title":"Landscape and spectrum of VWF variants in type 2 Von Willebrand Disease: insights from a German patient cohort","volume":"5","author":"Yadegari","year":"2025","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib12","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood.2021014729","article-title":"Structural basis of von Willebrand factor multimerization and tubular storage","volume":"139","author":"Zeng","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/beha.2001.0134","article-title":"A molecular approach to the classification of von Willebrand disease","volume":"14","author":"Schneppenheim","year":"2001","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.ymthe.2025.09.027_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(88)90511-9","article-title":"The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers","volume":"52","author":"Wise","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.09.027_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2009.03290.x","article-title":"Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage","volume":"7","author":"Haberichter","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1107\/S2059798317007446","article-title":"The ribosome and its role in protein folding: looking through a magnifying glass","volume":"73","author":"Javed","year":"2017","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ymthe.2025.09.027_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007526","article-title":"Protein folding and quality control in the ER","volume":"3","author":"Araki","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2025.09.027_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gt.2011.143","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","volume":"19","author":"Varadi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.09.027_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103867","article-title":"Endothelial Retargeting of AAV9 In Vivo","volume":"9","author":"Bozoglu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.09.027_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jth.13938","article-title":"High and long-term von Willebrand factor expression after sleeping beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease","volume":"16","author":"Portier","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1055\/s-0040-1715442","article-title":"Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA","volume":"120","author":"de Jong","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib22","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1182\/bloodadvances.2023010643","article-title":"Small interfering RNA-mediated allele-selective silencing of von Willebrand factor in vitro and in vivo","volume":"7","author":"Jongejan","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.09.027_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73592","article-title":"Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell","volume":"13","author":"Verma","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.09.027_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/537929","article-title":"Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study","volume":"2009","author":"Antoniou","year":"2009","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ymthe.2025.09.027_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-023-05962-2","article-title":"Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis","volume":"14","author":"Volpe","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.09.027_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.118.311587","article-title":"Human Cardiac Gene Therapy","volume":"123","author":"Ishikawa","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.09.027_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2024.02.002","article-title":"A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease","volume":"236","author":"Liang","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ymthe.2025.09.027_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymthe.2025.09.027_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-015-0166-9","article-title":"Mutations in the D1 domain of von Willebrand factor impair their propeptide-dependent multimerization, intracellular trafficking and secretion","volume":"8","author":"Yin","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2025.09.027_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153324","article-title":"HIF-1\u03b1 inhibits T-2 toxin-mediated \"immune evasion\" process by negatively regulating PD-1\/PD-L1","volume":"480","author":"You","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.ymthe.2025.09.027_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.09.027_bib32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2002-03-0789","article-title":"The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF","volume":"100","author":"Rosenberg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib33","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood.2020006005","article-title":"Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua","volume":"137","author":"Nair","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.09.027_bib34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/ATVBAHA.108.168369","article-title":"Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease","volume":"28","author":"De Meyer","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:55:52Z","timestamp":1766152552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625007555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625007555"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction of VWF multimerization in type 2A\/IIC von Willebrand disease by exogenous VWF propeptide supplementation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}